Methods
The sequencing of protease and part of reverse transcriptase region was performed using Trugene or ViroSeq assay. The prevalence of drug resistance mutations was estimated according to mutation list created for epidemiological estimates of transmitted resistance [1] . Class resistance was defined as the presence of at least one mutation associated with resistance to any drug in that class.
Summary of results
The study included 103 treatment naïve and 123 were cART experienced persons. In the treatment naïve group, the prevalence of transmitted DR was 3.9% classes of drugs (28%), followed by resistance to one class (13%). In two cases a three-class resistant strain was detected (1.6%). The most common were mutations associated with resistance to NRTIs (38%), followed by NNRTIs (24%) and PIs (15%).
Conclusion
The prevalence of DR mutations in both analyzed groups decreased when compared to previous studies from 2006 and 2002-2005 . It may be the effect of more effective antiretroviral drugs, incorporation of GT results into clinical practice, and/or growing awareness of the role of adherence. Transmission of DR mutations in Poland is limited to single classes which is concordant with the results of a study conducted by the SPREAD programme in Europe [2] . The publication of standardized lists of HIV-1 protease and reverse transcriptase mutations for DR surveillance [1] facilitates the comparison of results obtained in different countries.
